Dabur Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

Dabur Q3 results FY26 are scheduled to be announced on 29th January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Dabur Q3 Results 2026 Preview

• Dabur’s revenue is expected to be in the range of ₹3,355.25 crore, a 10.79% YoY increase. 
• Profit After Tax, or PAT, is projected to rise by 22.91% YoY. 
• Dabur’s EBITDA is expected to rise to ₹29.82 crore. 
• Net profit is ₹522.38 crore, a rise 22.91% YoY 

Dabur Share Performance 

• Over the past six months, Dabur’ share price has fallen by 6.30% to ₹2,261.00.
• Moreover, over the past year, the stock has decreased by 31.96%.
• Despite this weak short-term performance, Dabur’ stock has delivered a financially sound 167.61% return over the past 5 years.
• As of 28th January 2026, the stock traded at ₹2,261.00 per share.

Key Factors to Watch for Dabur Q3 Results FY26 

• Revenue & volume growth: Mid-single digit topline momentum as demand rebounds after GST revision and festive season sales.
• Profitability & margins: EBITDA and PAT performance reflecting cost control, premiumisation and product mix shifts.
• Rural vs urban demand: Consumer demand trends in rural markets relative to urban, especially for winter/health portfolios.
• International business contribution: Growth and profitability from exports and overseas markets, supporting diversified revenue.
• Category performance & new products: Segment-level momentum in oral care, hair care, health supplements, foods & premium offerings.

Final Thoughts

Dabur will announce its Q3 FY26 results on 29th January 2026. Analysts expect 610.79% YoY revenue growth, a 22.91% fall in PAT, and a 29.82% rise in EBITDA. Dabur focuses on recovery in underlying demand (especially post-GST relief), rural and international sales growth, premiumisation/product mix, and margin expansion alongside segment-level performance across health, personal care and foods.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Top 10 Penny Stocks in India | Penny Stocks to Buy in 2026

Best Stocks to Buy Today: Explore Best Stocks With Expected Trends

Milky Mist Dairy Foods IPO Details: Everything You Should Know about 

Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?

Taurian MPS IPO GMP & Review: Should You Apply or Avoid?

Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?

Dev Daburelerator IPO GMP & Review: Apply or Avoid?

Vigor Plast India IPO Listing Preview: What to Expect Now?

Krupalu Metals IPO GMP: Day 3 IPO Live Updates